Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Cancer Research
|
February 1, 1976
Potentiation of actinomycin D or adriamycin antitumor activity with DNA
T A Marks, J M Venditti
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1978
In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A
J M Venditti, R K Johnson
Investigational New Drugs
|
January 1, 1985
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review
A Goldin, J M Venditti, R Geran
Antibiotics and Chemotherapy
|
January 1, 1980
Usefulness and limitations of murine tumor models for the identification of new antitumor agents
A Goldin, R K Johnson, J M Venditti
Behring Institute Mitteilungen
|
May 1, 1984
Potentials and drawbacks of the human tumor stem cell assay
R H Shoemaker, M K Wolpert-DeFilippes, J M Venditti
Cancer Chemotherapy Reports
|
July 1, 1975
Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943)
R J Woodman, R L Cysyk, I Kline, et al.
Cancer Chemotherapy Reports
|
June 1, 1972
Influence of the stage of advancement of leukemia L1210 in mice on the optimal schedule of treatment of cytosine arabinoside (NSC-63878)
I Kline, R J Woodman, M Gang, et al.
International Journal of Cell Cloning
|
January 1, 1988
Relationship between in vitro tumor stem cell assay and in vivo antitumor activity using the P388 leukemia
J C Marsh, R H Shoemaker, S E Salmon, et al.
Journal of the National Cancer Institute
|
February 1, 1982
Calorie restriction: effect on growth of human tumors heterotransplanted in nude mice
B C Giovanella, R C Shepard, J S Stehlin, et al.
Cancer Research
|
April 1, 1988
Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue
A Rahman, J K Roh, M K Wolpert-DeFilippes, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Cancer Research
|
February 1, 1976
Potentiation of actinomycin D or adriamycin antitumor activity with DNA
T A Marks, J M Venditti
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1978
In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A
J M Venditti, R K Johnson
Investigational New Drugs
|
January 1, 1985
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review
A Goldin, J M Venditti, R Geran
Antibiotics and Chemotherapy
|
January 1, 1980
Usefulness and limitations of murine tumor models for the identification of new antitumor agents
A Goldin, R K Johnson, J M Venditti
Behring Institute Mitteilungen
|
May 1, 1984
Potentials and drawbacks of the human tumor stem cell assay
R H Shoemaker, M K Wolpert-DeFilippes, J M Venditti
Cancer Chemotherapy Reports
|
July 1, 1975
Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943)
R J Woodman, R L Cysyk, I Kline, et al.
Cancer Chemotherapy Reports
|
June 1, 1972
Influence of the stage of advancement of leukemia L1210 in mice on the optimal schedule of treatment of cytosine arabinoside (NSC-63878)
I Kline, R J Woodman, M Gang, et al.
International Journal of Cell Cloning
|
January 1, 1988
Relationship between in vitro tumor stem cell assay and in vivo antitumor activity using the P388 leukemia
J C Marsh, R H Shoemaker, S E Salmon, et al.
Journal of the National Cancer Institute
|
February 1, 1982
Calorie restriction: effect on growth of human tumors heterotransplanted in nude mice
B C Giovanella, R C Shepard, J S Stehlin, et al.
Cancer Research
|
April 1, 1988
Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue
A Rahman, J K Roh, M K Wolpert-DeFilippes, et al.
Page
of 2